成人钝性头部创伤患者颅内损伤患病率:抗凝或抗血小板药物使用与否的比较
该多中心前瞻性观察研究于2007年12月至2015年12月在美国3个急诊科纳入9,070例在急诊接受神经影像学检查的成人钝性头部创伤患者,记录伤前阿司匹林、氯吡格雷和华法林使用情况,主要终点为神经影像学上显著颅内损伤的患病率。与无任何凝血障碍的患者相比,单用华法林者显著颅内损伤的相对危险度为1.88(95%CI 1.28至2.75),阿司匹林联合氯吡格雷者为2.88(95%CI 1.53至5.42),单用阿司匹林者为1.29(95%CI 0.88至1.87),单用氯吡格雷者为0.75(95%CI 0.24至2.30)。作者结论认为伤前使用华法林或阿司匹林联合氯吡格雷者显著颅内损伤风险增加,而单用阿司匹林者未增加,并认为对此类患者进行神经影像学评估时应保持低阈值。
要点
- 伤前使用华法林者显著颅内损伤相对危险度为1.88(95%CI 1.28至2.75),高于无凝血障碍者。
- 伤前联合使用阿司匹林与氯吡格雷者显著颅内损伤相对危险度为2.88(95%CI 1.53至5.42)。
- 单用阿司匹林者相对危险度为1.29(95%CI 0.88至1.87),单用氯吡格雷者为0.75(95%CI 0.24至2.30),均未达统计学显著。
- 作者认为,评估使用华法林或阿司匹林联合氯吡格雷的患者时,进行神经影像学检查的阈值应较低。
适用人群与场景
- 美国3个急诊科中因钝性头部创伤接受神经影像学检查的成人患者。
- 记录伤前使用阿司匹林、氯吡格雷和华法林的情况;未专门记录直接口服抗凝药数据。
研究设计与关键结果
- 多中心前瞻性观察研究,2007年12月至2015年12月在美国3个急诊科纳入9,070例成人钝性头部创伤患者,中位年龄53.8岁(四分位距34.7至74.3岁),60.7%为男性。
- 1,323例(14.6%)使用抗血小板药物或华法林,其中单用阿司匹林635例、单用氯吡格雷109例、单用华法林406例。
- 与无任何凝血障碍者相比,显著颅内损伤的相对危险度:单用阿司匹林1.29(95%CI 0.88至1.87),单用氯吡格雷0.75(95%CI 0.24至2.30),单用华法林1.88(95%CI 1.28至2.75),阿司匹林联合氯吡格雷2.88(95%CI 1.53至5.42)。
证据类型、等级与局限
- 证据类型:多中心前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,评估使用华法林或阿司匹林联合氯吡格雷的钝性头部创伤成人时,进行神经影像学检查的阈值应较低。
- 单用阿司匹林者显著颅内损伤风险未达统计学显著升高,单用氯吡格雷者亦未达统计学显著。
- 本研究未专门记录直接口服抗凝药数据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: We determine the prevalence of significant intracranial injury among adults with blunt head trauma who are receiving preinjury anticoagulant or antiplatelet medications.
METHODS: This was a multicenter, prospective, observational study conducted from December 2007 to December 2015. Patients were enrolled in 3 emergency departments (EDs) in the United States. Adults with blunt head trauma who underwent neuroimaging in the ED were included. Use of preinjury aspirin, clopidogrel, and warfarin was recorded. Data on direct oral anticoagulants were not specifically recorded. The primary outcome was prevalence of significant intracranial injury on neuroimaging. The secondary outcome was receipt of neurosurgical intervention.
RESULTS: Among 9,070 patients enrolled in this study, the median age was 53.8 years (interquartile range 34.7 to 74.3 years) and 60.7% were men. A total of 1,323 patients (14.6%) were receiving antiplatelet medications or warfarin, including 635 receiving aspirin alone, 109 clopidogrel alone, and 406 warfarin alone. Compared with that of patients without any coagulopathy, the relative risk of significant intracranial injury was 1.29 (95% confidence interval [CI] 0.88 to 1.87) for patients receiving aspirin alone, 0.75 (95% CI 0.24 to 2.30) for those receiving clopidogrel alone, and 1.88 (95% CI 1.28 to 2.75) for those receiving warfarin alone. The relative risk of significant intracranial injury was 2.88 (95% CI 1.53 to 5.42) for patients receiving aspirin and clopidogrel in combination.
CONCLUSION: Patients receiving preinjury warfarin or a combination of aspirin and clopidogrel were at increased risk for significant intracranial injury, but not those receiving aspirin alone. Clinicians should have a low threshold for neuroimaging when evaluating patients receiving warfarin or a combination of aspirin and clopidogrel.
参考来源
- Probst MA, Gupta M, Hendey GW, et al. Prevalence of Intracranial Injury in Adult Patients With Blunt Head Trauma With and Without Anticoagulant or Antiplatelet Use. Ann Emerg Med. 2020. PMID: 31959538. doi:10.1016/j.annemergmed.2019.10.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。